Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Virgin HW"" wg kryterium: Autor


Tytuł:
Autophagy gene-dependent intracellular immunity triggered by interferon-γ.
Autorzy:
McAllaster MR; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA.; Vir Biotechnology , San Francisco, California, USA.
Bhushan J; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA.
Balce DR; Vir Biotechnology , San Francisco, California, USA.; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.
Orvedahl A; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.; Department of Pediatrics, Washington University School of Medicine , St. Louis, Missouri, USA.
Park A; Vir Biotechnology , San Francisco, California, USA.; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.
Hwang S; Vir Biotechnology , San Francisco, California, USA.
Sullender ME; Division of Infectious Diseases, Department of Medicine, Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine , St. Louis, Missouri, USA.
Sibley LD; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA.
Virgin HW; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.; Department of Internal Medicine, UT Southwestern Medical Center , Dallas, Texas, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2023 Oct 31, pp. e0233223. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Autorzy:
Momont C; Vir Biotechnology, San Francisco, CA, USA.
Dang HV; Vir Biotechnology, San Francisco, CA, USA.
Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Hauser K; Vir Biotechnology, San Francisco, CA, USA.
Wang C; Vir Biotechnology, St. Louis, MO, USA.
di Iulio J; Vir Biotechnology, San Francisco, CA, USA.
Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA.
De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Branch K; Vir Biotechnology, San Francisco, CA, USA.
Donermeyer D; Vir Biotechnology, St. Louis, MO, USA.
Vyas S; Vir Biotechnology, San Francisco, CA, USA.
Chen A; Vir Biotechnology, San Francisco, CA, USA.
Ferri E; Vir Biotechnology, San Francisco, CA, USA.
Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Powell AE; Vir Biotechnology, San Francisco, CA, USA.
Spreafico R; Vir Biotechnology, San Francisco, CA, USA.
Yim SS; Vir Biotechnology, San Francisco, CA, USA.
Balce DR; Vir Biotechnology, San Francisco, CA, USA.
Bartha I; Vir Biotechnology, San Francisco, CA, USA.
Meury M; Vir Biotechnology, San Francisco, CA, USA.
Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK.
Belnap DM; School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA.
Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Schaiff WT; Vir Biotechnology, St. Louis, MO, USA.
Miller JL; Vir Biotechnology, San Francisco, CA, USA.
Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Telenti A; Vir Biotechnology, San Francisco, CA, USA.
Virgin HW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Rosen LE; Vir Biotechnology, San Francisco, CA, USA.
Purcell LA; Vir Biotechnology, San Francisco, CA, USA.
Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Snell G; Vir Biotechnology, San Francisco, CA, USA. .
Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. .
Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Jul; Vol. 619 (7970), pp. E50.
Typ publikacji:
Published Erratum
Tytuł:
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Autorzy:
Momont C; Vir Biotechnology, San Francisco, CA, USA.
Dang HV; Vir Biotechnology, San Francisco, CA, USA.
Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Hauser K; Vir Biotechnology, San Francisco, CA, USA.
Wang C; Vir Biotechnology, St. Louis, MO, USA.
di Iulio J; Vir Biotechnology, San Francisco, CA, USA.
Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA.
De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Branch K; Vir Biotechnology, San Francisco, CA, USA.
Donermeyer D; Vir Biotechnology, St. Louis, MO, USA.
Vyas S; Vir Biotechnology, San Francisco, CA, USA.
Chen A; Vir Biotechnology, San Francisco, CA, USA.
Ferri E; Vir Biotechnology, San Francisco, CA, USA.
Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Powell AE; Vir Biotechnology, San Francisco, CA, USA.
Spreafico R; Vir Biotechnology, San Francisco, CA, USA.
Yim SS; Vir Biotechnology, San Francisco, CA, USA.
Balce DR; Vir Biotechnology, San Francisco, CA, USA.
Bartha I; Vir Biotechnology, San Francisco, CA, USA.
Meury M; Vir Biotechnology, San Francisco, CA, USA.
Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK.
Belnap DM; School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA.
Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Schaiff WT; Vir Biotechnology, St. Louis, MO, USA.
Miller JL; Vir Biotechnology, San Francisco, CA, USA.
Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Telenti A; Vir Biotechnology, San Francisco, CA, USA.
Virgin HW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Rosen LE; Vir Biotechnology, San Francisco, CA, USA.
Purcell LA; Vir Biotechnology, San Francisco, CA, USA.
Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Snell G; Vir Biotechnology, San Francisco, CA, USA. .
Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. .
Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Jun; Vol. 618 (7965), pp. 590-597. Date of Electronic Publication: 2023 May 31.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Viral*/chemistry
Antibodies, Viral*/immunology
Antibodies, Viral*/therapeutic use
Antibody Specificity*/immunology
Influenza A virus*/classification
Influenza A virus*/enzymology
Influenza A virus*/immunology
Influenza B virus*/classification
Influenza B virus*/enzymology
Influenza B virus*/immunology
Influenza Vaccines*/chemistry
Influenza Vaccines*/immunology
Influenza Vaccines*/therapeutic use
Influenza, Human*/immunology
Influenza, Human*/prevention & control
Neuraminidase*/antagonists & inhibitors
Neuraminidase*/chemistry
Neuraminidase*/immunology
Molecular Mimicry*
Animals ; Humans ; Mice ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/therapeutic use ; Arginine/chemistry ; Catalytic Domain ; Hemagglutinins, Viral/immunology ; Influenza A Virus, H3N2 Subtype/enzymology ; Influenza A Virus, H3N2 Subtype/immunology ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/prevention & control ; Seasons ; Sialic Acids/chemistry
Czasopismo naukowe
Tytuł:
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.
Autorzy:
Marzi R; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Bassi J; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Silacci-Fregni C; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Bartha I; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Muoio F; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Culap K; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Sprugasci N; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Lombardo G; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Saliba C; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Cameroni E; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Cassotta A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Low JS; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
Walls AC; Department of Biochemistry, University of Washington, Seattle, WA, USA.
McCallum M; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Dellota EA Jr; Vir Biotechnology, San Francisco, CA, USA.
Dillen JR; Vir Biotechnology, San Francisco, CA, USA.
Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA.
Pertusini L; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Terrot T; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Lepori V; Independent Physician, Bellinzona, Switzerland.
Tarkowski M; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milan, Italy.
Riva A; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milan, Italy.; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Biggiogero M; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland.
Franzetti-Pellanda A; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland.
Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
Ferrari P; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Clinical School, University of New South Wales, Sydney, NSW, Australia.
Ceschi A; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.
Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Havenar-Daughton C; Vir Biotechnology, San Francisco, CA, USA.
Telenti A; Vir Biotechnology, San Francisco, CA, USA.
Arvin A; Vir Biotechnology, San Francisco, CA, USA.
Virgin HW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Sallusto F; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Lanzavecchia A; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Corti D; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Piccoli L; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Pokaż więcej
Źródło:
IScience [iScience] 2023 Jan 20; Vol. 26 (1), pp. 105726. Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies